Détail de l'auteur
Auteur C. TRELOAR |
Documents disponibles écrits par cet auteur (27)
Article : Périodique
AIM: The potential for transmission of hepatitis C virus (HCV) in prison settings is well established and directly associated with sharing of injecting and tattooing equipment, as well as physical violence. This study is one of the first to exam[...]Article : Périodique
M. ALAVI ; J. GREBELY ; M. MICALLEF ; A. J. DUNLOP ; A. C. BALCOMB ; C. A. DAY ; C. TRELOAR ; N. BATH ; P. S. HABER ; G. J. DORE |BACKGROUND: Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic [...]Article : Périodique
R. WINTER ; S. FRASER ; N. BOOKER ; C. TRELOAR |Despite two decades of prevention activities and education, rates of hepatitis C infection remain high among people who inject drugs. In this article we draw on the findings of an extensive review of the content of print hepatitis C prevention m[...]Article : Périodique
C. TRELOAR ; H. WILSON ; L. MAO |Aims: Currently, efforts to prevent hepatitis C virus (HCV) focus on the message that all sharing of injecting equipment is risky. This obscures the strategies undertaken by people who inject drugs (PWID) to reduce risk of transmission to themse[...]Périodique
C. TRELOAR ; M. HOLT | 2006ENGLISH : Aims: To ascertain service providers' views on barriers and incentives to illicit drug users accessing or remaining in treatment. Methods: Interviews with service providers in Australia were conducted. Results: Two main themes were e[...]Article : Périodique
BACKGROUND: Women-only addiction services tend to be provided on a poorly evidenced assumption that women want single-sex treatment. We draw upon women's expectations and experiences of women-only residential rehabilitation to stimulate debate o[...]Rapport
C. TRELOAR ; P. HULL ; H. WILSON ; J. BRYANT | Sydney : National Centre in HIV Social Research (NCHSR) | 2009Key findings: Illicit drug use was common among attendees of the Big Day Out who resided in Queensland, with 61.5% reporting that they had used at least one illicit drug in the previous 12 months. The most commonly used drugs were cannabis (by 4[...]Article : Périodique
J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users |There have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017Bulletin : Périodique
International Journal of Drug Policy, Vol.26, n°10 - October 2015 - Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015Article : Périodique
Article : Périodique
S. LARNEY ; A. MADDEN ; A. D. MARSHALL ; N. K. MARTIN ; C. TRELOAR |The World Health Organisation has established a goal of eliminating the hepatitis C virus (HCV) as a public health threat by 2030. Considerable effort is being directed towards research to support and enhance HCV treatment uptake among people wh[...]Périodique
M. HOPWOOD ; C. TRELOAR ; J. BRYANT | 2006ENGLISH : Hepatitis C-related discrimination is reportedly common, however few studies have investigated this phenomenon. This paper presents findings from a cross-sectional study of people with self reported hepatitis C virus (HCV) infection [...]Périodique
J. BRYANT ; C. TRELOAR | 2008ENGLISH : Research about initiation to injecting drugs emphasises the role that relationships with others plays in the experience, suggesting investigations of initiation should include an examination of both initiates and initiators. This pap[...]Article : Périodique
Aims: The Lives of Substance (LoS) website presents personal experiences of drug use and 'addiction' in people's own words as part of a larger project of complicating public discourses of addiction, countering stigmatising misconceptions and act[...]Article : Périodique
A. MADDEN ; K. LANCASTER ; A. RITTER ; C. TRELOAR |Background: The importance of engaging people who use drugs in drug policy development is increasingly acknowledged including in recent UN documents. Little scholarly attention has been paid to 'drug user representation' in the global drug polic[...]Périodique
S. FRASER ; M. HOPWOOD ; C. TRELOAR ; L. BRENER | 2004ENGLISH : The term "needle fixation" is increasingly used by researchers and health professionals to explain a range of drug injecting attitudes and practices. This article employs an innovative discourse analysis approach to consider this not[...]Article : Périodique
Aims: This article reports on an evaluation of a community-controlled peer education project led by a drug user organization (DUO) that aimed to contribute to hepatitis C prevention. This article also examines broader contextual issues, particul[...]Article : Périodique
E. DAY ; T. BRODER ; J. BRUNEAU ; S. CRUSE ; M. DICKIE ; S. FISH ; C. GRILLON ; N. LUHMANN ; K. MASON ; E. MCLEAN ; S. TROOSKIN ; C. TRELOAR ; J. GREBELY |It is estimated that 6.1 million people with recent injecting drug use (PWID) are living with hepatitis C virus (HCV). Although HCV-related morbidity and mortality among PWID continues to increase, the advent of direct acting antiviral (DAA) HCV[...]Article : Périodique
ENGLISH : Despite evidence for their effectiveness, harm reduction services such as needle and syringe programmes (NSPs) are highly vulnerable to perceptions of community disapproval. This paper reviews Australian research on community attitud[...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]NouveautéRapport
C. TRELOAR ; J. ABELSON ; J. CRAWFORD ; KIPPAX S. ; J. HOWARD ; I. VAN BEEK ; J. COPELAND ; WEATHERALL A. M. ; A. MADDEN | Sydney : National Centre in HIV Social Research (NCHSR) | 2003This project, funded by NHMRC and NSW Health, aimed to investigate and report on a number of aspects of initiation and transition to injecting drug use among young people. The report focuses on issues of: - transition to injecting what drugs we[...]Périodique
J. ABELSON ; C. TRELOAR ; J. CRAWFORD ; KIPPAX S. ; I. VAN BEEK ; J. HOWARD | 2006ENGLISH : Aims This paper examines differences between early- and late-onset injection drug users (1216 years versus 1724 years) in terms of the antecedents and circumstances of first injection. Design Cross-sectional retrospective design, usi[...]Bulletin : Périodique
International Journal of Drug Policy, Vol.26, n°11 - November 2015 - Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015Bulletin : Périodique
International Journal of Drug Policy, Vol.72 - October 2019 - Striving towards the elimination of HCV infection among PWID
J. GREBELY, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; J. BRUNEAU, Éditeur scientifique ; J. V. LAZARUS, Éditeur scientifique ; B. HAJARIZADEH, Éditeur scientifique | 2019